KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Inventory Average: 2018-2024

Historic Inventory Average for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to $596.9 million.

  • Amneal Pharmaceuticals' Inventory Average rose 4.39% to $611.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $611.7 million, marking a year-over-year increase of 4.39%. This contributed to the annual value of $596.9 million for FY2024, which is 7.35% up from last year.
  • As of FY2024, Amneal Pharmaceuticals' Inventory Average stood at $596.9 million, which was up 7.35% from $556.1 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Inventory Average ranged from a high of $596.9 million in FY2024 and a low of $435.9 million during FY2020.
  • In the last 3 years, Amneal Pharmaceuticals' Inventory Average had a median value of $556.1 million in 2023 and averaged $554.3 million.
  • Data for Amneal Pharmaceuticals' Inventory Average shows a peak YoY grew of 12.43% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Amneal Pharmaceuticals' Inventory Average stood at $435.9 million in 2020, then grew by 12.43% to $490.0 million in 2021, then rose by 4.09% to $510.1 million in 2022, then grew by 9.02% to $556.1 million in 2023, then increased by 7.35% to $596.9 million in 2024.